SECreport

Form 3 BIOTIME INC For: May 20 Filed by: Leavitt Chase C.

Brooklyn ImmunoTherapeutics, Inc.  (BTX) 
NASDAQ:AMEX Investor Relations: biotimeinc.com/pexservice/investors